Table 1. Summary of the anti-carcinogenic effects of pomegranate-derived products.
Organ | Study Model | Pomegranate Formulation | Target/ Mechanism(s) | Reference |
---|---|---|---|---|
Prostate | ||||
Monolayer cell cultures |
Cold-pressed or CO2-extracted seed oil, fermented juice polyphenols, and pericarp polyphenols |
Inhibits proliferation and invasion Inhibits secretory phospholipase |
[26, 27] | |
Standardized extract (POMx, POM Wonderful) containing ellagitannins (37-40%) and ellagic acid (3.4%) but no anthocyanins; Juice (POM Wonderful) containing ellagitannins (1 mg/ml), ellagic acid (0.97 mg/ml) and anthocyanins; ellagitannins and ellagic acid |
Suppresses androgen receptor expression Inhibits androgen-synthesizing enzymes |
[29] | ||
Acetone extract of pomegranate fruit | Induces apoptosis Increases Bax/ Bcl-2 ratio Increases p21 & p27 Down-regulates cyclins and cdks |
[13] | ||
POMX prepared from skin and arils minus seeds and standardized to ellagitannins (37%) |
Induces apoptosis & inhibits cell growth Increases JNK phosphorylation Suppresses AKT/mTOR signaling Decreases IGF-1 mRNA levels |
[34] | ||
Fruit extract (POMX; POM Wonderful) standardized to ellagitannins [punicalagins] (37–40%), and ellagic acid (3.4%); Juice concentrate (POM Wonderful) containing punicalagins (1,561 mg/L), ellagic acid (121 mg/L), anthocyanins (387 mL/L), other hydrolysable tannins (417 mg/L) |
Inhibits NF-κB activity | [30] | ||
Juice (POM Wonderful) with flavonoids (anthocyanins, catechins, and phenols) constituting 40% of total polyphenols |
Antiproliferative, proapoptotic effects, increase in nitric oxide and reduction in oxidative state in exploratory bioassays |
[37] | ||
Pomegranate juice; ellagitannins extracted from POMX, urolithins |
Inhibits CYP enzyme activity | [40, 41] | ||
Pomegranate juice | Up-regulates anti-invasive mi-RNAs (−335,−205,−200, & −126) Down-regulates pro-invasive mi-RNA (−21 and −373) Reduces pro-inflammatory cytokines (IL-6,-12p40,-1β and Rantes) |
[36] | ||
Athymic nude mice |
Ellagitannin-rich fruit extract (POM Wonderful) standardized to ellagitannins [punicalagin] (37%) and ellagic acid (3.5%); acetone fruit extract |
Inhibits tumor growth & multiplicity Decreases serum PSA levels |
[32, 13] | |
Fruit extract (POMX; POM Wonderful) standardized to ellagitannins [punicalagins] (37–40%), and ellagic acid (3.4%); juice concentrate (POM Wonderful) containing punicalagins (1,561 mg/L), ellagic acid (121 mg/L), anthocyanins (387 mL/L), and other hydrolysable tannins (417 mg/L) |
Delays emergence of androgen independence Decreases NF-κB activity |
[30] | ||
TRAMP mice | Acetone extract of pomegranate fruit | Reduces tumor formation Decreases metastasis Increases survival Inhibits IGF-I/AKT/mTOR signaling |
[33] | |
Human trials | Juice (POM Wonderful) with flavonoids (anthocyanins, catechins, and phenols) constituting 40% of total polyphenols; pomegranate extract (POMX) |
Increases PSA doubling time Disease stabilization |
[37, 38] | |
Monolayer cell cultures |
Acetone extract of pomegranate fruit | Inhibits UVA-mediated phosporylation of STAT3, AKT, ERK1/2, mTOR & p70S6K Decreases PCNA & Ki-67 expression Up-regulates Bax & Bad Down-regulates Bcl-XL |
[42] | |
Acetone extract of pomegranate fruit | Inhibits UVB-mediated MAPK phosphorylation; NF-κB/p65 activation | [43] | ||
Pomegranate extract POMX (POM Wonderful) with 135000 ppm polyphenols with major constituents gallic acid equivalent and ellagitannins |
Protects keratinocytes from UV-B-induced oxidative stress and photo-aging Inhibits UV-B-mediated decrease in cell viability and intracellular GSH content; increase in lipid peroxidation & up-regulation of MMPs −1,−2,−7 and −9 Inhibits MAPKs; c-Jun |
[44] | ||
Skin | ||||
Pomegranate fruit extract standardized to ellagitannins [gallic acid & punicalagins] (37.5%) and ellagic acid (2.7%) |
Protects fibroblasts from cell death post UV Decreases NF-κB activity | [45] | ||
Aqueous extracts of pomegranate juice, peel and seed (POM Wonderful) |
Facilitates skin repair Stimulates type I procollagen synthesis Inhibits MMP-1 production |
[54] | ||
3-D EpiDerm | Pomegranate extract POMX (POM Wonderful) with 135000 ppm polyphenols with major constituents gallic acid equivalent and ellagitannins; POMx juice (POM Wonderful) contains anthocyanins, ellagitannins and hydrolyzable tannins; POM seed oil (POM Wonderful) |
Inhibits UVB-induced CPDs & 8-OHdG formation; PCNA expression Increases p21 Inhibits UVB-induced MMPs-1,-2,-3,-7,-8,-9,-11,-12; c-Jun and c-Fos; tropoelastin expression |
[46] | |
SKH-1 mice | Acetone extract of pomegranate fruit | Inhibits UVB-induced skin edema, hyperplasia, leukocytic infiltration; lipid peroxidation; CPDs & 8-OHdG formation; PCNA, ODC & COX-2 expressions; MAPK phosporylation; NF-κB/p65 activation, phosporylation of c-Jun; MMPs -2,-3,-9 expression Increases p53 and p21 expressions |
[47, 48] | |
CD-1 mice SKH-1 mice |
Pomegranate seed oil; Acetone extract of pomegranate fruit |
Decreases tumor incidence & multiplicity Inhibits TPA-mediated increase in skin edema and hyperplasia; ODC activity, COX-2 expression; phosphorylation of MAPKs and NF-κB activity |
[52, 31] | |
Balb/c mice | Pomegranate fruit extract | Delays onset and incidence of tumor Suppresses MAPKs and NF-κB activity |
[53] | |
Wistar rats | Methanolic extract of dried pomegranate peel | Accelerates wound healing Increases hydroxyproline content |
[55] | |
Guinea pigs | Methanolic pomegranate peel extract based- ointment |
Accelerates wound healing | [56] | |
Colon | ||||
Monolayer cell cultures |
Punicalagin, ellagic acid, standardized pomegranate tannin extract (punicalagin 85%, ellagic acid 1.3% and ellagitannins 12%) and pomegranate juice; POMX (POM Wonderful) |
Induces apoptosis, cell cycle arrest Inhibits growth |
[35, 64] | |
Pomegranate fruit extract standardized to ellagitannins [punicalagin α and β] (25%) and ellagic acid (3.5%) |
Inhibits Wnt signaling | [67] | ||
Ellagic acid; urolithins | Inhibits migration and adhesion Inhibits activation of NF-κB & MAPKs Down-regulates COX-2, PGE2, PAI-1 and IL-8 |
[58] | ||
Pomegranate juice (POM Wonderful) (punicalagin 1.74 g/L), pomegranate tannin extract and punicalagins |
Suppresses TNFα-induced COX-2 expression, AKT & NF-κB activity | [65] | ||
F344/Ducrj rats | Pomegranate seed oil | Inhibits the incidence and multiplicity of azoxymethane-induced colonic adenocarcinomas Increases PPAR expression |
[68] | |
TNBS mouse model |
Ellagic acid | Attenuates morphologic alterations associated with cellular injury Maintains glandular architecture Decreases inflammatory cells infiltrate Represses COX-2 and iNOS Inhibits MAPKs and NF-κB signaling |
[59] | |
Punicic acid | Down-regulates neutrophil hyper-activation Decreases ROS-induced tissue damage |
[60] | ||
DSS mouse model |
Pomegranate extract standardized to punicalagins (35%), punicalin (13%), ellagic acid glucoside (4.5%) and ellagic acid (8.9%); urolithin A |
Decreases inflammation markers (iNOS, COX-2, PTGES and PGE2) | [61] | |
Pomegranate flower extract; ellagic acid rich fraction from pomegranate extract |
Attenuates oxidative stress and subsequent colonic inflammation | [63] | ||
Lung | ||||
Monolayer cell cultures |
Aqueous extract of pomegranate peel | Anti-oxidant Inhibits myeloperoxidase activity |
[70] | |
Acetone extract of pomegranate fruit | Decreases cell viability Induces p21 and p27 protein expressions Down-regulates cyclins/cdks Decreases PCNA & Ki67 expression Inhibits MAPKs; PI3K/AKT pathway, NF-κB activity |
[71] | ||
Athymic nude mice |
Acetone extract of pomegranate fruit | Inhibits tumor growth | [71] | |
A/J mice | Acetone extract of pomegranate fruit | Decreases tumor incidence & multiplicity Inhibits phosphorylation of MAPKs; PI3K/ AKT/mTOR pathway; NF- κB/p65 activation Inhibits c-Met phosphorylation Decreases Ki-67 & PCNA; iNOS, CD31 & VEGF |
[14] | |
Breast | ||||
Monolayer cell cultures |
Urolithins | Inhibits aromatase activity Inhibits proliferation |
[72] | |
Punicic acid; Cold-pressed or CO2-extracted seed oil, fermented juice polyphenols, and aqueous pericarp extract |
Inhibits proliferation Induces apoptosis dependent on lipid peroxidation and the PKC pathway |
[74, 73] | ||
Pomegranate fruit extract | Suppresses NF-κB Decreases RhoC and RhoA |
[78] | ||
Pomegranate seed oil; fermented juice polyphenols |
Down-regulates VEGF and MIF | [79] | ||
Organ culture | Fermented juice polyphenols | Reduces DMBA-induced lesions | [73, 76] | |
Blood | ||||
Monolayer cell cultures |
PSP001polysaccharide from pomegranate rind | Inhibits leukemia cell growth | [80] | |
Pomegranate juice; pomegranate ellagitannin nanoparticles |
Induces apoptosis; cell cycle arrest | [81, 82] | ||
Pomegranate ellagitannin nanoparticles | Promotes differentiation in promyelocytic leukemia cells | [82] |